ARPP19 promotes MYC expression and associates with patient relapse in acute myeloid leukemia
biorxiv(2019)
摘要
Together, these data identify ARPP19 as a novel oncogenic PP2A inhibitor protein in AML, and demonstrate its risk group independent role in predicting AML patient relapse tendency.
更多查看译文
关键词
Cancer,ARPP-19,PME-1,SET,WT1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要